Autoimmunity in Inner Ear Disease

Stopped early · Phase 3

Conditions studied: Hearing Loss, Sensorineural

In brief

The purpose of this study is to determine whether prednisone, methotrexate, and cyclophosphamide are effective in the treatment of rapidly progressive sensorineural hearing loss in both ears. This condition is called autoimmune inner ear disease (AIED), because it is thought that the hearing loss is triggered by an autoimmune process. Treatment attempts to suppress or control this process with powerful anti-inflammatory drugs. This is a Phase III, outpatient study. All study participants will be assigned to one of four different groups testing the experimental use of drugs. The study is scheduled to run for 18 months, with a minimum of 11 visits per participant.

Key facts

Study ID

NCT00000361

Run by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Starts

1998-03-01

Expected to finish

2002-11-01

Last updated by the study team

2006-04-24

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have sensorineural (nerve/inner ear) hearing loss of at least 30 dB in each ear, which has rapidly progressed.
• Are in good general health.
• Are sterile or use contraception (if a woman of child-bearing age).
• Are able to speak and understand English or Spanish.

You may not qualify if…

• Have had any previous reaction to prednisone, or history of psychiatric reaction to corticosteroids.
• Have used corticosteroids for more than 30 days within the past 90 days. Patients who have been off corticosteroids for at least 30 days may be eligible.
• Have any significant heart, lung, digestive, blood, or neurologic disorders.
• Have tuberculosis (TB), brittle or unstable insulin-dependent diabetes mellitus, active malignancy or prior chemotherapy, pancreatitis, active peptic ulcer disease, kidney failure, history of shingles, or known (other) autoimmune disease.
• Have had a positive test for HIV, hepatitis C or B.
• Have any type of middle ear disorder.
• Are breast-feeding or pregnant.

Where it is running

• House Ear Institute — Los Angeles, California, United States
• UCSD Medical Center — San Diego, California, United States
• Univ of Iowa Hosp and Clinic — Iowa City, Iowa, United States
• Johns Hopkins Univ — Baltimore, Maryland, United States
• Massachusetts Eye and Ear Infirmary — Boston, Massachusetts, United States
• Univ of Michigan — Ann Arbor, Michigan, United States
• New York University — New York, New York, United States
• Cleveland Clinic Foundation — Cleveland, Ohio, United States
• University of Texas, Southwestern Medical Center at Dallas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.